PharmaCorp Rx (TSXV:PCRX) Accounts Payable: C$2.38 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSXV:PCRX PharmaCorp Rx Inc TSXV:PCRX
35 GF Score
Price C$0.51
! 2 Warning Signs
View Full Analysis

What is PharmaCorp Rx Accounts Payable?

PharmaCorp Rx TSXV:PCRX -1.92% 35 Accounts Payable is C$2.38 Mil as of Mar. 2026. GuruFocus rates TSXV:PCRX with a GF Score™ of 35/100. The stock has 2 warning signs investors should review.

PharmaCorp Rx's Accounts Payable for the quarter that ended in Mar. 2026 was C$2.38 Mil.

PharmaCorp Rx's quarterly Accounts Payable increased from Sep. 2025 (C$2.84 Mil) to Dec. 2025 (C$5.20 Mil) but then declined from Dec. 2025 (C$5.20 Mil) to Mar. 2026 (C$2.38 Mil).

PharmaCorp Rx's annual Accounts Payable increased from Dec. 2023 (C$0.05 Mil) to Dec. 2024 (C$1.54 Mil) and increased from Dec. 2024 (C$1.54 Mil) to Dec. 2025 (C$5.20 Mil).

PharmaCorp Rx Accounts Payable Related Terms

PharmaCorp Rx Accounts Payable Historical Data

* Premium members only.

The historical data trend for PharmaCorp Rx's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PharmaCorp Rx Accounts Payable Chart

PharmaCorp Rx Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Accounts Payable
0.03 0.02 0.05 1.54 5.20

PharmaCorp Rx Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.44 1.97 2.84 5.20 2.38
TSXV:PCRX
35GF Score
PharmaCorp Rx Inc TSXV:PCRX
Accounts Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PharmaCorp Rx Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of C$2.38 Mil mean?
PharmaCorp Rx (TSXV:PCRX) has a Accounts Payable of C$2.38 Mil as of Mar. 2026. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on PharmaCorp Rx and its competitors.
Is PharmaCorp Rx's Accounts Payable too high?
PharmaCorp Rx's current Accounts Payable is C$2.38 Mil. Overall, PharmaCorp Rx has a GF Score™ of 35/100, reflecting its overall financial health beyond just this single metric.
How does PharmaCorp Rx's Accounts Payable compare to competitors?
PharmaCorp Rx's Accounts Payable of C$2.38 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Healthcare Providers & Services company?
A good Accounts Payable depends on the Healthcare Providers & Services industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on PharmaCorp Rx and its competitors. PharmaCorp Rx's current Accounts Payable is C$2.38 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PharmaCorp Rx stock overvalued right now?
PharmaCorp Rx (TSXV:PCRX) has a current Accounts Payable of C$2.38 Mil. The current Accounts Payable is C$2.38 Mil. PharmaCorp Rx's overall GF Score™ is 35/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For PharmaCorp Rx (TSXV:PCRX), the current Accounts Payable is C$2.38 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PharmaCorp Rx Business Description

Address 303 Wellman Lane, Suite 203, Saskatoon, SK, CAN, S7T 0J1
PharmaCorp Rx Inc operates three PharmaChoice bannered pharmacies in Canada and will continue to acquire PharmaChoice Canada-branded pharmacies as it come to market in conjunction with its strategic alliance agreement with PharmaChoice Canada. The company will also acquire independently owned non-PharmaChoice Canada-bannered pharmacies in Canada, and thereafter, continue to operate such acquired pharmacies under a PharmaChoice Canada banner.
35GF Score

Get the complete analysis for TSXV:PCRX

Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

C$0.51
Price